Brachytherapy
Volume 6, Issue 1 , Pages 49-52 , January 2007

Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancer

  • Karl Mikael Kälkner

      Affiliations

    • Department of Oncology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Department of Oncology, Radiumhemmet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. Tel.: +46-8-517-79927.
    • ,
  • Emil Bengtsson

      Affiliations

    • Department of Medical Physics, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Simone Eriksson

      Affiliations

    • Department of Medical Physics, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Carina Holmberg

      Affiliations

    • Department of Oncology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Sten Nilsson

      Affiliations

    • Department of Oncology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Seymour Levitt

      Affiliations

    • Department of Oncology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    • Department of Therapeutic Radiology, University of Minnesota, Minneapolis, MN
    • ,
  • Marie Lundell

      Affiliations

    • Department of Medical Physics, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden

Received 30 June 2006 ,Revised 21 August 2006 ,Accepted 24 August 2006.

References 

  1. Cancer Incidence in Sweden 2002. Vol. 2003: The National Board of Health and Welfare Centre for Epidemiology. http://www.sos.sc/sos/statisti.htm, December 2003.
  2. Jackson A, Skwarchuk MW, Zelefsky MJ, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 2001;49:685–698
  3. Wachter S, Gerstner N, Goldner G, et al. Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors. Radiother Oncol. 2001;59:65–70
  4. Vordermark D, Schwab M, Ness-Dourdoumas R, et al. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol. 2003;69:209–214
  5. Borghede G, Hedelin H, Holmang S, et al. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol. 1997;44:237–244
  6. Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer. I. Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys. 2000;47:103–113
  7. Yeoh EE, Botten R, Russo A, et al. Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys. 2000;47:915–924
  8. al-Abany M, Helgason AR, Cronqvist AK, et al. Dose to the anal sphincter region and risk of fecal leakage. Acta Oncol. 2004;43:117–118
  9. Anagnostopoulos G, Baltas D, Geretschlaeger A, et al. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2003;57:1183–1191

PII: S1538-4721(06)00253-4

doi: 10.1016/j.brachy.2006.08.008

Brachytherapy
Volume 6, Issue 1 , Pages 49-52 , January 2007

Article Tools

* Image Usage & Resolution